Alcentra Capital Corp. (NASDAQ:ABDC) – Equities researchers at DA Davidson issued their Q2 2017 earnings estimates for Alcentra Capital Corp. in a research report issued to clients and investors on Wednesday. DA Davidson analyst A. Cyganovich expects that the asset manager will post earnings per share of $0.34 for the quarter. DA Davidson currently has a “Buy” rating and a $15.00 target price on the stock. DA Davidson also issued estimates for Alcentra Capital Corp.’s Q3 2017 earnings at $0.36 EPS, Q4 2017 earnings at $0.36 EPS, FY2017 earnings at $1.40 EPS, Q1 2018 earnings at $0.36 EPS, Q2 2018 earnings at $0.37 EPS, Q3 2018 earnings at $0.37 EPS, Q4 2018 earnings at $0.38 EPS and FY2018 earnings at $1.48 EPS.

ILLEGAL ACTIVITY WARNING: “Equities Analysts Issue Forecasts for Alcentra Capital Corp.’s Q2 2017 Earnings (ABDC)” was first posted by American Banking News and is the property of of American Banking News. If you are accessing this piece of content on another domain, it was illegally copied and republished in violation of United States and international trademark and copyright law. The correct version of this piece of content can be read at https://www.americanbankingnews.com/2017/07/07/equities-analysts-issue-forecasts-for-alcentra-capital-corp-s-q2-2017-earnings-abdc.html.

A number of other equities research analysts also recently weighed in on the stock. Keefe, Bruyette & Woods started coverage on shares of Alcentra Capital Corp. in a research note on Tuesday, April 11th. They set a “market perform” rating and a $14.00 price target for the company. TheStreet raised shares of Alcentra Capital Corp. from a “c” rating to a “b-” rating in a research note on Monday, April 3rd. Three equities research analysts have rated the stock with a hold rating and one has given a buy rating to the company’s stock. The company presently has an average rating of “Hold” and a consensus target price of $13.67.

Shares of Alcentra Capital Corp. (ABDC) opened at 13.29 on Friday. Alcentra Capital Corp. has a one year low of $11.17 and a one year high of $14.73. The company’s 50-day moving average is $13.48 and its 200-day moving average is $13.16.

The company also recently disclosed a quarterly dividend, which was paid on Thursday, July 6th. Investors of record on Friday, June 30th were issued a dividend of $0.34 per share. This represents a $1.36 dividend on an annualized basis and a yield of 10.23%. The ex-dividend date of this dividend was Wednesday, June 28th. Alcentra Capital Corp.’s dividend payout ratio is currently 340.00%.

In related news, major shareholder Of New York Mellon Corp Bank sold 1,691,839 shares of the business’s stock in a transaction that occurred on Monday, May 22nd. The shares were sold at an average price of $13.13, for a total transaction of $22,213,846.07. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link. 4.96% of the stock is currently owned by insiders.

A number of hedge funds and other institutional investors have recently modified their holdings of the stock. Creative Planning boosted its position in shares of Alcentra Capital Corp. by 2.9% in the first quarter. Creative Planning now owns 20,570 shares of the asset manager’s stock worth $283,000 after buying an additional 570 shares in the last quarter. Wells Fargo & Company MN boosted its position in shares of Alcentra Capital Corp. by 4.9% in the first quarter. Wells Fargo & Company MN now owns 28,835 shares of the asset manager’s stock worth $396,000 after buying an additional 1,354 shares in the last quarter. Confluence Investment Management LLC boosted its position in shares of Alcentra Capital Corp. by 6.3% in the first quarter. Confluence Investment Management LLC now owns 203,962 shares of the asset manager’s stock worth $2,803,000 after buying an additional 12,030 shares in the last quarter. Ares Management LLC boosted its position in shares of Alcentra Capital Corp. by 3.5% in the first quarter. Ares Management LLC now owns 434,049 shares of the asset manager’s stock worth $5,964,000 after buying an additional 14,525 shares in the last quarter. Finally, Guggenheim Capital LLC boosted its position in shares of Alcentra Capital Corp. by 57.3% in the fourth quarter. Guggenheim Capital LLC now owns 67,654 shares of the asset manager’s stock worth $810,000 after buying an additional 24,637 shares in the last quarter. Hedge funds and other institutional investors own 43.46% of the company’s stock.

Alcentra Capital Corp. Company Profile

Alcentra Capital Corporation is a specialty finance company that operates as a non-diversified, closed-end management investment company. The Company operates as a business development company and a regulated investment company. It provides customized debt and equity financing solutions to lower middle-market companies, which are companies having annual earnings, before interest, taxes, depreciation and amortization of between $5 million and $15 million, and/or revenues of between $10 million and $100 million.

Earnings History and Estimates for Alcentra Capital Corp. (NASDAQ:ABDC)

Receive News & Ratings for Alcentra Capital Corp. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Alcentra Capital Corp. and related companies with MarketBeat.com's FREE daily email newsletter.